Wierod L, Rosseland CM, Lindeman B, Oksvold MP, Grosvik H, Skarpen E, Huitfeldt HS(2008) Activation of the p53-p21(Cip1) pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytes Oncogene, 27(19), 2763-2771 DOI 10.1038/sj.onc.1210937
Yri OE, Ekstrom PO, Hilden V, Gaudernack G, Liestol K, Smeland EB, Holte H(2013) Influence of polymorphisms in genes encoding immunoregulatory proteins and metabolizing enzymes on susceptibility and outcome in patients with diffuse large B-cell lymphoma treated with rituximab Leuk. Lymphoma, 54(10), 2205-2214 DOI 10.3109/10428194.2013.774392
Belnoue E, Di Berardino-Besson W, Gaertner H, Carboni S, Dunand-Sauthier I, Cerini F, Suso-Inderberg EM, Walchli S, Konig S, Salazar AM, Hartley O, Dietrich PY, Walker PR, Derouazi M(2016) Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants Mol. Ther., 24(9), 1675-1685 DOI 10.1038/mt.2016.134